Carl Icahn to go public with his opposition to Cigna-Express Scripts merger

Carl Icahn is going public with his campaign to scuttle Cigna Corp.’s $54 billion plan to buy Express Scripts Holding Co.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.